What is the correct way to take lapatinib/telisa

Lapatinib (Lapatinib) is an oral small molecule dual-target inhibitor of HER2 and EGFR. Its use method has an important impact on the efficacy and safety. In the treatment of breast cancer, taking it correctly can maximize its anti-tumor effect while reducing the risk of adverse reactions. According to overseas guidelines and clinical practice experience, the dosage of lapatinib needs to be adjusted according to combined drugs and pathological types.

For patients with HER2-positive metastatic breast cancer in combination with capecitabine, the recommended dose of lapatinib is 1250 mg orally once daily in 21-day cycles. Lapatinib can be taken at least one hour before or after a meal to ensure stable drug absorption. The recommended dose of capecitabine combined with it is 2000mg/m²/day, taken orally in two divided doses, about 12 hours apart, for 14 consecutive days followed by a 7-day break. It also needs to be taken with food or within 30 minutes after a meal. Such a dosage arrangement can ensure a reasonable superposition of the blood concentrations of the two drugs, thus enhancing the combined efficacy.

In the treatment of hormone receptor-positive, HER2-positive metastatic breast cancer, the recommended dose of lapatinib is 1500 mg orally once daily in combination with letrozole. At this time, lapatinib should also be taken at least one hour before or after a meal, while the recommended dose of letrozole is 2.5 mg daily. Taking lapatinib at one time can maintain the stability of the blood concentration and avoid fluctuations in efficacy caused by divided doses. Therefore, it is not recommended to divide the dose into multiple oral doses.

In addition, patients need to pay attention to the storage conditions of the drug during the medication process to avoid moisture, high temperature or light affecting the stability of the drug. If digestive tract discomfort or mild rash occurs, symptomatic treatment can be taken under the guidance of a physician, but the dosage should not be adjusted or the medication discontinued on your own. Overall, following the recommended dosage and taking time, combined with a combination drug strategy, can maximize the clinical efficacy of lapatinib while reducing the risk of adverse events.

Reference materials:https://medlineplus.gov/druginfo/meds/a607055.html